Case number 1:23-cv-00334
Bayer Intellectual Property GmbH et al v. Biocon Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 7, 2023 | 15 | SO ORDERED Granting (D.I. 14 in 23-cv-334-RGA; D.I. 170 in 21-md-3017-RGA) Stipulation of Dismissal between Plaintiffs and Defendants Biocon Pharma Limited, Biocon Limited, and Biocon Pharma, Inc.. Signed by Judge Richard G. Andrews on 8/7/2023. Associated Cases: 1:21-md-03017-RGA, 1:23-cv-00334-RGA(nms) (Entered: 08/07/2023) (2) |
| Aug 7, 2023 | 16 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2; 10,828,310 B2. (Attachments: # 1 Order)(nms) (Entered: 08/07/2023) (0) |
| Aug 4, 2023 | 14 | STIPULATION of Dismissal between Plaintiff and Defendants Biocon Pharma Limited, Biocon Limited, and Biocon Pharma, Inc., by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/7/2023 (nms). (Entered: 08/04/2023) (2) |
| Jul 27, 2023 | 13 | STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/27/2023 (nms). (Entered: 07/27/2023) (2) |
| Jun 20, 2023 | 12 | STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Pharma AG. (Fahnestock, Derek) Modified on 6/20/2023 (nms). (Entered: 06/20/2023) (2) |
| Jun 20, 2023 | N/A | SO ORDERED, re 12 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Biocon Limited answer due 7/28/2023; Biocon Pharma Limited answer due 7/28/2023; Biocon Pharma, Inc. answer due 7/28/2023). Signed by Judge Richard G. Andrews on 6/20/2023. (nms) (Entered: 06/20/2023) (0) |
| May 11, 2023 | 11 | STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Smith, Rodger) Modified on 5/11/2023 (nms). (Entered: 05/11/2023) (2) |
| May 11, 2023 | N/A | SO ORDERED, re 11 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Biocon Limited answer due 6/23/2023; Biocon Pharma Limited answer due 6/23/2023; Biocon Pharma, Inc. answer due 6/23/2023). Signed by Judge Richard G. Andrews on 5/11/2023. (nms) (Entered: 05/11/2023) (0) |
| Apr 25, 2023 | 8 | SUMMONS Returned Executed by Bayer Intellectual Property GmbH, Bayer AG, Janssen Pharmaceuticals, Inc., Bayer Pharma AG.Biocon Limited served on 4/21/2023, answer due 5/12/2023. (Fahnestock, Derek) (Main Document 8 replaced on 4/25/2023) (nms). (Entered: 04/25/2023) (2) |
| Apr 25, 2023 | 9 | SUMMONS Returned Executed by Bayer Intellectual Property GmbH, Bayer AG, Janssen Pharmaceuticals, Inc., Bayer Pharma AG.Biocon Pharma, Inc. served on 4/21/2023, answer due 5/12/2023. (Fahnestock, Derek) (Main Document 9 replaced on 4/25/2023) (nms). (Entered: 04/25/2023) (2) |
| Apr 25, 2023 | 10 | SUMMONS Returned Executed by Bayer Intellectual Property GmbH, Bayer AG, Janssen Pharmaceuticals, Inc., Bayer Pharma AG.Biocon Pharma Limited served on 4/21/2023, answer due 5/12/2023. (Fahnestock, Derek) (Entered: 04/25/2023) (2) |
| Apr 25, 2023 | N/A | CORRECTING ENTRY: The pdf for D.I. 8 and D.I. 9 have been replaced per the filer's request. The word "Alia" has been removed above the title. The NEFS for the filings have been regenerated. (nms) (Entered: 04/25/2023) (0) |
| Mar 29, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:23-cv-00327-UNA, 1:23-cv-00334-UNA, 1:23-cv-00335-UNA(nms) (Entered: 03/29/2023) (0) |
| Mar 24, 2023 | 1 | COMPLAINT filed against Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc. ( Filing fee $ 402, receipt number ADEDC-4097330.) - filed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer Pharma AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(apk) (Entered: 03/27/2023) (Main Document) (19) |
| Mar 24, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 03/27/2023) (3) |
| Mar 24, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/17/23. Date of Expiration of Patent: (SEE ANDA FORM).Thirty Month Stay Deadline: 8/17/2025. (apk) (Entered: 03/27/2023) (1) |
| Mar 24, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2 ;10,828,310 B2. (apk) (Entered: 03/27/2023) (1) |
| Mar 24, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GmbH, Bayer Pharma AG filed by Bayer Intellectual Property GmbH, Bayer Pharma AG. (apk) (Entered: 03/27/2023) (1) |
| Mar 24, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (apk) (Entered: 03/27/2023) (1) |
| Mar 24, 2023 | 7 | Summons Issued as to Biocon Limited on 3/26/2023; Biocon Pharma Limited on 3/26/2023; Biocon Pharma, Inc. on 3/26/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(apk) (Entered: 03/27/2023) (Main Document) (2) |
| Mar 24, 2023 | N/A | Remark: MDL Panel has been advised of this new action. (apk) (Entered: 03/28/2023) (0) |
| Mar 24, 2023 | 7 | Summons Issued as to Biocon Limited on 3/26/2023; Biocon Pharma Limited on 3/26/2023; Biocon Pharma, Inc. on 3/26/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(apk) (Entered: 03/27/2023) (Summons Issued) (2) |
| Mar 24, 2023 | 7 | Summons Issued as to Biocon Limited on 3/26/2023; Biocon Pharma Limited on 3/26/2023; Biocon Pharma, Inc. on 3/26/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(apk) (Entered: 03/27/2023) (Summons Issued) (2) |
| Mar 24, 2023 | 1 | COMPLAINT filed against Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc. ( Filing fee $ 402, receipt number ADEDC-4097330.) - filed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer Pharma AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(apk) (Entered: 03/27/2023) (Exhibit A) (14) |
| Mar 24, 2023 | 1 | COMPLAINT filed against Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc. ( Filing fee $ 402, receipt number ADEDC-4097330.) - filed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer Pharma AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(apk) (Entered: 03/27/2023) (Exhibit B) (27) |
| Mar 24, 2023 | 1 | COMPLAINT filed against Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc. ( Filing fee $ 402, receipt number ADEDC-4097330.) - filed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer Pharma AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(apk) (Entered: 03/27/2023) (Civil Cover Sheet) (2) |
